Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

299
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
299
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

663
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
663
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

654
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
654
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

602
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
602
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

1.3K
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
1.3K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Stacking-Enhanced Support Vector Regression Model for Predicting the Hot Deformation Flow Stress of TC18 Alloy.

Materials (Basel, Switzerland)·2026
Same author

Lactic acid facilitates the generation of regulatory T cells and promotes cancer progression by activating latent TGF-β1.

International immunopharmacology·2026
Same author

A novel score to predict successful endovascular recanalization of non-acute carotid artery occlusion.

Journal of neurointerventional surgery·2026
Same author

Unraveling stepwise pressure effects on interfacial structure and electrochemical dynamics in sulfide-based all-solid-state Lithium batteries.

Journal of colloid and interface science·2026
Same author

Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma.

Molecular cancer·2026
Same author

Nitroreductase-Activated Fluorescent Probes: From Molecular Design to Disease Diagnosis.

ChemMedChem·2026
Same journal

Widening Health Inequality and Causal Metabolic Drivers in Global Colorectal Cancer: A Multi-Dimensional Study.

Cancer informatics·2026
Same journal

GFAP-Dependent Transcriptional Dynamics and Cellular Heterogeneity in Primary, Recurrent, and Grade III Gliomas.

Cancer informatics·2026
Same journal

Translating Data Into Clinical Tools: An Integrative Strategy for Precision Biomarker Identification in Soft Tissue Sarcoma Diagnosis and Prognosis.

Cancer informatics·2026
Same journal

The MAPK Pathway Coordinates an Immunosuppressive Microenvironment in Colorectal Cancer: A Single-Cell Guided Prognostic Model.

Cancer informatics·2026
Same journal

Multi-Scale Cross-Attention Multiple Instance Learning Network for Automated Classification of Colorectal Polyps.

Cancer informatics·2026
Same journal

LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies.

Cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Mar 3, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K

A mixture copula Bayesian network model for multimodal genomic data.

Qingyang Zhang1, Xuan Shi2

  • 1Department of Mathematical Sciences, University of Arkansas, USA.

Cancer Informatics
|May 5, 2017
PubMed
Summary
This summary is machine-generated.

We introduce a flexible mixture copula Bayesian network for causal inference in complex, non-Gaussian data. This approach improves accuracy for genomic data analysis, outperforming traditional Gaussian models.

Keywords:
Bayesian networkcopula functionserous ovarian cancersystems biologythe Cancer Genome Atlas

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K

Related Experiment Videos

Last Updated: Mar 3, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.4K
Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K

Area of Science:

  • Computational biology
  • Statistical genetics
  • Machine learning

Background:

  • Gaussian Bayesian networks are standard for causal inference but fail with non-Gaussian data.
  • Genomic datasets, like The Cancer Genome Atlas, often violate normality assumptions.
  • Existing methods lack flexibility for multimodal and non-Gaussian biological data.

Purpose of the Study:

  • To develop a novel Bayesian network model for flexible causal inference in non-Gaussian and multimodal data.
  • To enhance prediction accuracy for complex biological and genomic datasets.
  • To apply the new model to Cancer Genome Atlas data for ovarian cancer pathway analysis.

Main Methods:

  • Proposed a mixture copula Bayesian network model for non-Gaussian data.
  • Utilized an expectation-maximization algorithm for efficient parameter estimation.
  • Developed a heuristic search algorithm with Bayesian information criterion for network structure learning.
  • Employed ensemble prediction from multiple random initializations for improved accuracy.

Main Results:

  • The mixture copula Bayesian network demonstrated superior modeling flexibility and prediction accuracy compared to Gaussian and regular copula Bayesian networks.
  • The method was validated using cell signaling data.
  • Applied successfully to The Cancer Genome Atlas data for studying ovarian cancer pathways.

Conclusions:

  • Mixture copula Bayesian networks offer a powerful and flexible framework for causal inference with non-Gaussian and multimodal data.
  • The developed methods provide significant improvements in prediction accuracy for complex biological data.
  • This approach is well-suited for analyzing large-scale genomic datasets like The Cancer Genome Atlas.